StockNews.com began coverage on shares of Bio-Path (NASDAQ:BPTH – Free Report) in a research report sent to investors on Friday. The firm issued a sell rating on the stock.
Bio-Path Stock Performance
Shares of NASDAQ:BPTH opened at $0.63 on Friday. Bio-Path has a twelve month low of $0.59 and a twelve month high of $9.83. The business has a fifty day moving average of $0.89 and a 200-day moving average of $0.99.
Bio-Path Company Profile
Further Reading
- Five stocks we like better than Bio-Path
- Short Selling: How to Short a Stock
- NVIDIA’s Hidden AI Play: The Truth Behind Its WeRide Investment
- What Percentage Gainers Tell Investors and Why They Don’t Tell the Whole Story
- Up 50% in January, Twilio’s Pullback Is the Time to Buy
- What is Forex and How Does it Work?
- Watch These 3 Stocks—High Short Interest and Big Upside Potential
Receive News & Ratings for Bio-Path Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Bio-Path and related companies with MarketBeat.com's FREE daily email newsletter.